Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: COVPRIG robustly predicts the overall survival of IDH wild-type glioblastoma and highlights METTL1+ neural-progenitor-like tumor cell in driving unfavorable outcome

Fig. 2

Construction and evaluation of COVPRIG. K–M analysis of the A TCGA RNAseq (train) and CGGA693 (external validation) and B TCGA microarray (train) and GSE16011 (external validation). C ROC curves based on the TCGA RNAseq cohort. D AUCs of the 4 cohorts. E The discriminative ability of COVPRIG. Group 1 was set as the reference. Decision curves based on the F TCGA RNAseq and G TCGA microarray cohorts. H The Nomogram for RNAseq and microarray-based cohorts

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us